Scorpion Therapeutics Stock

Scorpion Therapeutics is a precision oncology company that broadens the reach and impact of precision medicine for cancer patients.

Sign up today and learn more about Scorpion Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Scorpion Therapeutics Stock

Scorpion Therapeutics was founded to broaden the reach and impact of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology.

Funding History

October 2020$108M
January 2021$162M



Gaddy Getz

Interim Chief Executive Officer

Adam Friedman

Co-Founder & Board Member

Keith Flaherty

Chief Financial Officer

Brian Piper


Liron Bar-Peled

Board Observer

Paulina Hill


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: